-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
vTv Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
- vTv Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.51M, a 21.2% decline year-over-year.
- vTv Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$24M, a 11.6% increase year-over-year.
- vTv Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$25.5M, a 13.1% decline from 2022.
- vTv Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$22.5M, a 4.05% decline from 2021.
- vTv Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$21.7M, a 82.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)